← Back to Patent Explorer
US4390541A Expired / Lapsed US ⏱️ 0.0 years remaining

Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease

Assignee: Lilly Industries Ltd
•
Filing: 1981-12-03
•
Granted: 1983-06-28
•
Expires: 2001-12-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the following formula are described: ##STR1## in which n is 0, 1 or 2, R 1 is C 1-4 alkyl, C 1-4 alkoxy, C 1-4 alkylthio, C 1-4 alkylsulphonyl, trifluoromethyl, halo or nitro, and R 2 and R 3 are each independently hydrogen or C 1-4 alkyl, and salts thereof. The compounds are useful in the treatment of immediate hypersensitivity conditions and are prepared by reaction of the appropriate formylquinolone with malonic acid, ylid or phosphonate.

Inventors

  • 👤 John Goldsworthy
  • 👤 William J. Ross
  • 👤 John P. Verge

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 06:03
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/22; C07D215/233; A; A61; A61P; A61P37/00; A61P37/08; C07C; C07C255/00; C07D215/24; C07D215/26; C07D215/36; C07D215/48; C07D215/54; C07D215/56

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 48 words
A compound of formula ##STR10## in which n is 0,1 or 2, R 1 is C 1-4 alkyl, C 1-4 alkoxy, C 1-4 alkylthio, C 1-4 alkylsulphonyl, trifluoromethyl, halo or nitro, and R 2 and R 3 are each independently hydrogen or C 1-4 alkyl, and salts thereof.
Claim 2
Dependent Claim 48 words
A compound of formula ##STR10## in which n is 0,1 or 2, R 1 is C 1-4 alkyl, C 1-4 alkoxy, C 1-4 alkylthio, C 1-4 alkylsulphonyl, trifluoromethyl, halo or nitro, and R 2 and R 3 are each independently hydrogen or C 1-4 alkyl, and salts thereof.
Claim 3
Dependent Claim 44 words
A compound according to claim 1 in which n is 0 or 1, R 1 is C 1-4 alkoxy, C 1-4 alkylthio, trifluoromethyl, nitro or chloro and is in the 6 or 8 position, and R 2 and R 3 are hydrogen or methyl.
Claim 4
Dependent Claim 27 words
A compound according to claim 2 in which n is 1, the substituent being in the 6 position, R 2 is methyl and R 3 is hydrogen.
Claim 5
Dependent Claim 36 words
A compound according to claim 1 in which n is 0 or 1, R 2 is trifluoromethyl or chloro in the 7 position, R 2 is methyl or butyl and R 3 is hydrogen or ethyl.
Claim 6
Dependent Claim 27 words
A pharmaceutical formulation comprising a compound of formula (I) as defined in claim 1, or a pharmaceutically acceptable salt thereof, in association with a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim 41 words
A method of controlling an immediate hypersensitivity disease in an animal, including a human, which comprises administering to the animal a therapeutically effective amount of a compound of formula (I) as defined in claim 1, or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

GB830832A Cited
GB1433774A Cited
US4330549A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-06-27 1986-12-27 1987-06-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-06-27 1990-12-27 1991-06-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-06-27 1994-12-27 1995-06-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag